Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Electrical Nerve Stimulation During Sleep for Memory Consolidation

14 giugno 2026 aggiornato da: Xidian University

Effects of 2 Hz and 120 Hz Transcutaneous Electrical Nerve Stimulation During Sleep on Procedural Memory and Working Memory: A Randomized, Sham-Controlled, Crossover Study

The purpose of this study is to investigate the effects of transcutaneous electrical nerve stimulation (eTNS) applied during sleep on memory consolidation and brain-body physiological coupling. Healthy college students will participate in four overnight sleep sessions in a standard sleep laboratory.

Before going to sleep, participants will learn and complete two cognitive tasks: a motor sequence tapping task to assess procedural memory, and an N-back task to assess working memory. During the night, participants will receive either 2 Hz eTNS, 120 Hz eTNS, or a sham (placebo) stimulation on their forehead in a randomized order. Throughout the night, researchers will record their sleep using polysomnography (PSG), along with continuous monitoring of heart rate (ECG) and breathing (respiration). Upon waking the next morning, participants will be re-tested on both memory tasks.

The primary objective is to determine whether eTNS during sleep can improve behavioral performance on procedural and working memory tasks overnight. Secondary objectives include analyzing the stimulation's effects on specific sleep brain wave patterns (such as slow oscillations and sleep spindles) and exploring the coupling mechanisms between brain activity, heart rhythms (Heartbeat Evoked Potentials), and respiration during sleep.

Panoramica dello studio

Descrizione dettagliata

This study utilizes a randomized, double-blind, sham-controlled, within-subject crossover design to evaluate the modulatory effects of transcutaneous electrical nerve stimulation (eTNS) during sleep on memory consolidation and cardiopulmonary-brain coupling.

Healthy young adults will be recruited and rigorously screened to exclude those with sleep disorders, neurological or psychiatric conditions, or recent use of medications affecting sleep or cognition. Each participant will complete four overnight sessions in a standard soundproof and lightproof sleep laboratory, separated by 5-7 days. The first night serves as an adaptation night with no stimulation or data collection. The subsequent three nights involve experimental recordings under varying stimulation conditions (2 Hz eTNS, 120 Hz eTNS, and sham stimulation) applied in a randomized order.

Experimental Procedure:

On experimental nights, participants will arrive at the laboratory at 21:00. Prior to sleep, participants will undergo a training and baseline testing phase for two distinct cognitive tasks: a procedural memory task (the classic sequential finger-tapping task) and a working memory task (the 2- to 5-back task). Following the pre-sleep tasks, participants will be fitted with polysomnography (PSG) equipment, electrocardiogram (ECG) sensors, and respiratory monitors. Lights-out is scheduled for 23:00. Upon awakening between 07:00 and 08:00 the following morning, participants will be re-tested on both the sequential finger-tapping task and the N-back task to assess overnight memory consolidation.

Stimulation Parameters:

During sleep, eTNS will be delivered via a three-channel current source stimulator connected to self-adhesive silicone electrodes placed above the left and right eyebrows. The stimulation consists of biphasic rectangular pulses with a 250 μs pulse width. For the active conditions (120 Hz or 2 Hz), the current is delivered in cycles of 30 seconds on and 30 seconds off. The current intensity will be titrated to a subjective score of 3-4 on a numerical rating scale (NRS), perceived as a mild tingling sensation that does not disrupt sleep. The sham condition delivers current only for the first two minutes (the first two cycles) to mimic the initial sensation of the active conditions. All stimulations automatically terminate after a maximum duration of 8 hours.

Data Collection and Analysis Framework:

Continuous PSG recording (including standard EEG, EOG, and EMG based on the international 10-20 system) will be synchronized with simultaneous ECG and respiration data. The study will primarily compare the pre- and post-sleep behavioral improvements across the three stimulation conditions. Furthermore, the neurophysiological data will be analyzed to extract sleep structural features, slow oscillation (SO) and sleep spindle metrics, and complex physiological interactions. Specific focus will be placed on SO-spindle coupling, SO-respiration coupling, and Heartbeat Evoked Potentials (HEP) to elucidate the underlying neural and autonomic mechanisms by which peripheral stimulation influences cognitive functions during sleep.

Tipo di studio

Interventistico

Iscrizione (Stimato)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Shaanxi
      • Xi'an, Shaanxi, Cina, 71000
        • Reclutamento
        • Xidian University
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Descrizione

Inclusion Criteria:

  1. Healthy young adults (e.g., college students), aged generally between 18 and 30 years.
  2. Right-handed.
  3. Body Mass Index (BMI) ≤ 30 kg/m^2.
  4. Capable of fully comprehending the experimental procedures and voluntarily signing the informed consent form.

Exclusion Criteria:

  1. History or current presence of neurological disorders, psychiatric disorders, or brain damage.
  2. History or current presence of cardiovascular diseases (e.g., arrhythmias or abnormal nocturnal heart rate).
  3. Presence of depressive or anxiety symptoms (assessed by Patient Health Questionnaire-9 [PHQ-9] score > 9, or Generalized Anxiety Disorder-7 [GAD-7] score > 9).
  4. Presence of sleep disturbances or poor sleep quality (assessed by Insomnia Severity Index [ISI] score > 8, or Pittsburgh Sleep Quality Index [PSQI] score > 10).
  5. Any medication use within the past six months that could affect stress responses, cognitive abilities, or sleep architecture.
  6. History of smoking or alcohol abuse.
  7. Known skin allergies to conductive paste, medical tape, or silicone electrodes.
  8. Female participants who are in their menstrual period during the scheduled experimental sessions (sessions must be strategically scheduled to avoid this period).
  9. Inability or refusal to abstain from caffeine, tea, and alcohol for at least 24 hours prior to and during the experimental sessions.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 120 Hz Transcutaneous Electrical Nerve Stimulation
Participants will receive 120 Hz transcutaneous electrical nerve stimulation (eTNS) during nighttime sleep. The stimulation is delivered via a current source stimulator connected to self-adhesive silicone electrodes placed above the left and right eyebrows. The stimulation consists of biphasic rectangular pulses with a 250 μs pulse width at a frequency of 120 Hz. It is delivered in continuous cycles of 30 seconds on and 30 seconds off. Before sleep, the current intensity is individually titrated to elicit a mild tingling sensation (corresponding to a score of 3-4 on a numerical rating scale) that will not disrupt the participant's sleep. The stimulation protocol automatically terminates after a duration of 8 hours.
Sperimentale: 2 Hz Transcutaneous Electrical Nerve Stimulation
Participants will receive 2 Hz transcutaneous electrical nerve stimulation (eTNS) during nighttime sleep. The stimulation is delivered via a current source stimulator connected to self-adhesive silicone electrodes placed above the left and right eyebrows. The stimulation consists of biphasic rectangular pulses with a 250 μs pulse width at a frequency of 2 Hz. It is delivered in continuous cycles of 30 seconds on and 30 seconds off. Before sleep, the current intensity is individually titrated to elicit a mild tingling sensation (corresponding to a score of 3-4 on a numerical rating scale) that will not disrupt the participant's sleep. The stimulation protocol automatically terminates after a duration of 8 hours.
Comparatore placebo: Sham Stimulation (Placebo)
Participants will receive a sham stimulation designed to serve as a placebo control. The equipment setup, including the placement of self-adhesive silicone electrodes above the left and right eyebrows, is identical to the active eTNS conditions. The current intensity is initially adjusted before sleep to elicit the same mild tingling sensation (a score of 3-4 on a numerical rating scale). However, to maintain double-blinding without providing a therapeutic dose, the stimulator only delivers current output during the first 2 minutes of the night (i.e., exactly two cycles of 30 seconds on and 30 seconds off). After these initial 2 minutes, the current output ceases entirely for the remainder of the 8-hour sleep period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Procedural Memory Performance
Lasso di tempo: Assessed pre-sleep (approx. 21:00-22:00) and post-sleep (approx. 07:00-08:00 the following morning), representing an overnight interval of approximately 10 hours.
Procedural memory consolidation will be assessed using the classic sequential finger-tapping task (SFTT). Performance improvement is calculated as the difference in speed (number of correct sequences typed) and accuracy between the pre-sleep training/testing session and the post-sleep testing session. A larger positive difference indicates better procedural memory consolidation overnight.
Assessed pre-sleep (approx. 21:00-22:00) and post-sleep (approx. 07:00-08:00 the following morning), representing an overnight interval of approximately 10 hours.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Working Memory Performance
Lasso di tempo: Assessed pre-sleep (approx. 21:00-22:00) and post-sleep (approx. 07:00-08:00 the following morning), representing an overnight interval of approximately 10 hours.
Working memory performance will be assessed using the 2- to 5-back task. Outcome metrics include reaction time and accuracy (hit rate and false alarm rate). The overnight change is calculated by comparing the performance in the post-sleep testing session to the pre-sleep baseline session. Higher accuracy and shorter reaction times indicate improved working memory function.
Assessed pre-sleep (approx. 21:00-22:00) and post-sleep (approx. 07:00-08:00 the following morning), representing an overnight interval of approximately 10 hours.
Sleep Architecture and Sleep Efficiency
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period.
Sleep architecture will be derived from PSG scoring according to the American Academy of Sleep Medicine (AASM) criteria. Key metrics include Total Sleep Time (TST), Sleep Efficiency (SE, calculated as TST divided by Time in Bed), and the percentage of time spent in different sleep stages (N1, N2, N3, and REM sleep). This ensures the stimulation does not negatively disrupt normal sleep patterns.
Continuously recorded during the 8-hour nighttime sleep period.

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Sleep Slow Oscillation (SO) Density and Amplitude
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period (from lights out at 23:00 to waking up between 07:00 and 08:00).
Extracted from continuous Polysomnography (PSG) recordings (specifically at C3 and C4 channels). SO density (number of slow oscillations per minute) and peak-to-peak amplitude will be analyzed during Non-Rapid Eye Movement (NREM) sleep stages 2 and 3 to evaluate the depth and quality of slow-wave sleep.
Continuously recorded during the 8-hour nighttime sleep period (from lights out at 23:00 to waking up between 07:00 and 08:00).
Sleep Spindle Density and Amplitude
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period.
Extracted from PSG recordings at central electrodes (C3, C4). Fast sleep spindle density (number of spindles per minute) and amplitude will be calculated during NREM sleep stages 2 and 3.
Continuously recorded during the 8-hour nighttime sleep period.
Slow Oscillation-Spindle Coupling
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period.
This coupling will be evaluated by calculating the SO-spindle coupling ratio (the proportion of spindles coupled with SOs relative to the total number of spindles) and the preferred phase angle of spindle maxima relative to the SO phase. This metric reflects the coordination of memory-related brain rhythms.
Continuously recorded during the 8-hour nighttime sleep period.
Brain-Body Coupling: SO-Respiration Synchronization
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period.
Evaluated by analyzing the phase-locking or temporal synchronization between respiratory phases (extracted from simultaneous respiratory monitor data) and the occurrence/phase of sleep slow oscillations (extracted from EEG) during NREM sleep.
Continuously recorded during the 8-hour nighttime sleep period.
Brain-Body Coupling: Heartbeat Evoked Potentials (HEP)
Lasso di tempo: Continuously recorded during the 8-hour nighttime sleep period.
HEP amplitude will be calculated by time-locking the EEG signals to the R-peaks of the simultaneous electrocardiogram (ECG) data during sleep. This measure assesses the cortical representation of afferent cardiac signals and heart-brain interactions.
Continuously recorded during the 8-hour nighttime sleep period.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

16 giugno 2026

Completamento primario (Stimato)

30 luglio 2026

Completamento dello studio (Stimato)

31 luglio 2026

Date di iscrizione allo studio

Primo inviato

14 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 giugno 2026

Primo Inserito (Effettivo)

18 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Volontari Sani (HV)

Prove cliniche su 120 Hz Transcutaneous Electrical Nerve Stimulation

Sottoscrivi